Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Big news coming... as I said previously Lifeline Biotechnologies is no where to be found anymore, been wiped clean from the web- all Cyrcadia Health now for the iTBra Launch...(as well as the CH revised website).$$$
iTBra is a novel breast health screening device and method based on disruptive technology and tissue health science. The system is a non-invasive breast physiology screening system, much more sensitive and much more cost effective than mammography. The platform has applications for both OB/GYN and primary care in-office use, as well as potential use as an over-the-counter (OTC) diagnostic system.
$$$ OTC
Some of the companies operating in healthcare artificial intelligence market space include AiCure, Cyrcadia Health-(LLBO), Google, IBM, and Microsoft. Increasing investments by industry players and growing interest of venture capital firms will spur revenue growth. Healthcare artificial intelligence industry is witnessing growth in startup units in recent years and the trend is anticipated to continue over the forecast period.
Cyrcadia has and will be seeking multiple resources to execute its business plan, including major companies interested in Cyrcadia's technology and its proven early breast cancer detection process.
No more Lbti.com—previous Post #26739 Oct 4
Whois.domaintool
Website Title Home | Lifeline Biotechnologies
Server Type Apache/2.4.34 (Amazon) OpenSSL/1.0.2k-fips PHP/5.6.37
Lbti.com
7,314 days old
Created on 1998-09-30
Expires on 2018-09-29
Updated on 2009-08-12
LLBO website has expired...Captain, it is entirely logical the iT Bra is to be “branded” under one name (Cyrcadia
Health), yes Spock in all probability you may be right...prepare for Launch !
Captain, yes Mr Sulu, we have intercepted the repeating message again it appears to be rapidly repeating, appears to be coming from their Ambassador Jim Holmes...Listen...
“after over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product”.
Scotty, we need more power I still cannot access my Broker to buy more shares !
(As goofy as I am it should be very clear that something is about to happen)
Arnie -Mead all on the money “Disruptive Technology”
Most interesting is that The Propell Group likes to invest in companies that could be “disruptive technology”,still
invested in Cyrcadia...
https://www.silkroad40.com/new-iot-bra-can-detect-early-signs-breast-cancer/
(newbie article)
Interesting, I searched lbti.com today & Godaddy pops up with this:
“Notice: This domain name expired on 9/29/2018 and is pending renewal or deletion.Welcome to lbti.com”
(But still if u Google LLBO or lifeline biotechnologies u still get lbti.com & the Warning???)
Interesting, maybe they are dropping the website. So if that’s the case which it may be since CH is under revision. How do they plan on using the Stock symbol LLBO (Maybe a symbol change coming)? appears to me a big change coming!
Like u said we shall see.
Hey, I noticed a couple of neg post, hope there’s more we’re getting attention...!
As they say, let the games begin...! I thought the same thing about Cytosorbents, and then one day folks said
Jed ya out move away from there, Beverly Hills is the place ya outa be, & they thought to themselves if only I
had bought that worthless penny stock...!
Cutestat com website evaluation, results for lbti.com
“3.12 Rating by CuteStat
lbti.com is 1 decade 9 years old. It is a domain having .com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, lbti.com is SAFE to browse.
Updated 6 minutes 21 seconds ago”
So the lbti google search “Warning May be all Google”. Regardless still needs to be fixed ASAP!!!
Still getting Warning for Virus, as previously stated doing LLBO Google search or Lifeline Biotechnologies
????
Leprisonner/Mead, no I have no news. Mead have u contacted CH ? (per the receptionist yesterday Jim was to
be informed of the problem ASAP about the website (LLBO)Google Virus warning. This is an easy fix, I’m surprised it’s not corrected as yet). This is NOT a good time to have one under review CH & one with Virus warning !!! Also, as previously posted I sent Rob Royea a Tweet.
PCM good find on Asia article, they just seem to keep coming. Most interesting I find (sad though), is the young
incident age, but with youth comes modern technology. Asians love tech. & the iTBra fits right in, no pun intended. So can u conclude they will adopt the iTBra ?
Another interesting point is the Author is US based (his comment on the US mkt being so much larger, let’s wish
the iTBra success in Asia, US next).
Good article, familiar with much of it, but not the connectivity past issue, very interesting...
https://www.silkroad40.com/new-iot-bra-can-detect-early-signs-breast-cancer/
“New Iot Bra can detect early signs of breast cancer silkroad
OK, Co. contact has been made & they will be looking into the LLBO-Google- Malware issue.
(Good thing too because old Friend of mine back in my Dean Witter brokerage days called me about the problem after I told him about the stock, and of course he checked out the CH website only to find it under review. Fortunately he didn’t stop there and read up on the Asian release as well as wanting to release in the US as soon as possible etc. etc.)
Looks like he is coming on board, he owns 2 homes over a mil each, hopefully he will tell his buddies.
Rrao— my brother in law got back to me computer software architect expert, Looked at both lifeline and CH websites, very possible lifeline has been attacked & CH not enough info, but a possibility. OK gets more interesting, neighbor down the street called me while writing this post, is a cyber security consultant in the computer software etc., & says this happens every day to many of his clients... usually easy to fix if given attention. ( and although hard to PenPoint some are done by competitors).
Wow this is all new to me but I guess we read about it pretty much every day.
Could it be some of our competitors maybe the boys down in Mexico? Who knows maybe they don’t like what’s about to happen with the iT Bra Asia release, but let’s look at the positive here if competitors don’t like what’s about to happen then what’s about to happen is got to be disruptive technology...as my father always said read between the lines.
Hell I hope we get hacked more looks like we’ve got someone’s attention!
I have contacted the Co regarding Malware warning & will probably send a certified letter if not immediately corrected. LLBO Google search—clk lbti.com
As it turns out this could be a competitor infiltration ... after reading up on the subject, maybe one of you has much more knowledge regarding computer viruses that myself?
Well my question just got answered finally got a hold of the wife and she said the same thing on her work computer ...
So time to contact the company and they need to get this immediately immediately fixed somehow someway ?
Question is anyone getting this message after Googling LLBO
& then clicking on lbti.com
Warning — visiting this web site may harm your computer!
Please let me know (& I don’t mean entering lbti.com, but clicking on
the Google find lbti.com
If everyone is getting the warning after googling LLBO & click on lbti .com then this is a real problem
And immediately needs to be addressed by Cyrcadia Health.
After finding out this answer we can contact the Co.
The first thing I do when researching a company is to do a Google search on the stock symbol. If I was looking at this the first time and I got that warning red flags would be shooting off everywhere...In this case we know better, but new people might not !
Lifeline Biotechnologies Subsidiary (Cyrcadia Inc. / Cyrcadia Health) ?
Co’s freshen their image by changing the name of the company to better reflect what products and services it produces. (IBM use to be IT-International Totalizer) !
Cyrcadia Health iT Bra sounds much better than Lifeline Biotechnologies /First Warning System
( obviously this will represent the product better)
So is CI website reopening going to coincide with Asia product launch ? Survey says Yes, when? don’t know,
but an educated guess says soon.
When will Lifeline Biotechnologies outdated website be updated ? (Very important, inv will flock to it upon Asia dist.)
(Just sent Jim/Rob questions about the LB website...& subsidiary as posted on CH website (they do state in some news stories 45% PLUS ownership- does plus mean 51% plus & majority on the board making CI a sub.,or 46-50% equity investment meaning just that. Per below old news release.
“Lifeline announces transfer of breast cancer detection technology to “subsidiary”
by admin | Jun 30, 2017 | News
Reno-based Lifeline Biotechnologies, Inc. (OTC PINK: LLBO) recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. common stock and a $110,000 cash and $220,000 promissory note. The additional 4,670,000 shares added to Lifeline’s original 8,000,000 shares totals 12,670,000 shares. Lifeline’s ownership is increased to over 45 percent of Cyrcadia, Inc., making Lifeline Cyrcadia, Inc.’s largest single shareholder.”
Well just passing the lull by !!!
I smell the launch coming...soon.
E72 This is Houston we have confirmed launch count down..10-9-
Oops this Conf !
Al Medical Asia Conference
Nov 8-10, Hangzhou, China
“ artificial intelligence (AI) in medicine and health care”.
(Note-One of the speakers is John Mattison assistant medical director chief health information officer of Kaiser Permanent Health, Kaiser is one of the companies Cyrcadia Health is pursuing with the IT bra, I mentioned Kaiser many months ago in my AARP post Virtual Medicine before Cyrcadia made it public knowledge(post-new investor information.)My only point being that the conference speakers are medical people not product Companies & I would certainly think the iT Bra technology would be discussed in the Digital Medicine & Wearable Technology sec5 below ?)
Entry Categories:
1. Decision support and hospital monitoring
2. Medical Imaging and Biomedical Diagnostics
3. Precision Medicine and Drug Discovery
4. Cloud Computing and Data Security
5. Digital Medicine and “”Wearable Technology””
6. Robotic Technology and Virtual Reality
“AI Med Conf: is a unique collaboration between innovative medical and technology entrepreneurs that seeks new ways of thinking about healthcare delivery in the 21st Century. It brings together innovative technology providers, policy makers, executives and leading thinkers to imagine new models of healthcare service delivery, engagement and mobility that puts patients at the centre of the AI healthcare revolution.”
Sally Daub, Board Member and Executive Advisor, Enlitic”
Tic toc ...
Maybe a launch before Conf., just a thought ?
(Good article below mentions IFlytech Co. and wearables great need in China, & I wonder who has invested in the iT Bra, OH iFlytech Co. !)
https://www.google.com/amp/s/techwireasia.com/amp/2018/06/chinas-quest-for-better-healthcare-with-ai/
FDA Class11 (mid of article):
Cyrcadia, Inc. Prepares for iTBra™ Product Launch and Expands Strategic Operations to Asia
by admin | Apr 25, 2017 | News
Cyrcadia, Inc.(CI) announced this week a strategic expansion to accelerate operations and market launch into Asia for early breast cancer monitoring. CI has entered into a License and Cooperation Agreement Cyrcadia Asia, Ltd. (CA), a newly formed company in Hong Kong which will serve as the base for the Asia market launch of CI’s proprietary iTBraTM technology expected to commence in late 2017 or early 2018 under the global CI brand of Cyrcadia Health. Under the License and Cooperation Agreement, Cyrcadia Asia has exclusive marketing rights to the iTBra technology and products in Asia. CA will assume and fund certain further product development and other activities with respect to the iTBra technology and products for the benefit of both CI and CA. The License and Cooperation Agreement also provides for certain other financial terms between the two parties intended to enable the launch of the technology and products in Asia. CI retains exclusive marketing rights to the United States, Mexico and Canada, with the marketing strategy for the iTBra technology and products in other countries to be further discussed by the parties. Having obtained U.S. FDA 510(k) Class II approval for its iTBra technology, CI has conducted clinical trials in the U.S. with its newly developed scalable product, which demonstrates greatly improved outcomes, beyond historical product results. CI’s predictive analytic artificial intelligence (AI) based technology now demonstrates 80%+ accuracy with a two-hour wear when compared with the original trials which required 48-hour wear and achieved 74% accuracy. CI and CA expect this greatly improved performance to support the use of the 510(k) approval to launch the technology and products...
FDA Class11: (last par)
Cyrcadia, Inc. Wins Prestigious Cannes Lions Awards
by admin | Jul 25, 2017 | News
Cyrcadia, Inc. (CI) announced it has won two prestigious awards at the Cannes Lions International Festival of Creativity, a global event for the creative communications, marketing and advertising world. Held in Cannes, France and attended by over 10,000 delegates, Lion awards are considered the most coveted in the industry. The first award was a Bronze Lion in the category of Innovation, which honors ground-breaking technology and problem-solving. It specifically looks at how technology, data and ideas, when working in unison, can revolutionize lives. Cyrcadia shared the Bronze award with industry giants such as Google, Shell and Apple. The second award was a Silver Glass Lion award, recognizing ideas that could change the world and positively impact gender inequality or injustice. Cyrcadia’s ability to deliver early breast cancer health monitoring to the mass populations of women who have little or no access to quality health care was key to Cyrcadia’s award achievement. Cyrcadia is developing and marketing a device and software that monitors for biometric changes that correlate to breast cancer . Known as the iTBra, the device is based on wearable sensor patches that are placed under a woman’s own garments and worn for two hours. The sensor data results processed through Cyrcadia’s artificial intelligence (AI) lab can be automatically communicated to the patient, her physician and insurance company. Based on Cyrcadia’s monitoring device, a patient will be recommended for further investigation by a physician. The company’s technology has obtained U.S. FDA 510(k) Class II clearance. While the technology is based on historic data from a trial of 200 patients, recent validation trials on 46 patients have confirmed prior...
Just got done posting some of these LLBO articles on Yahoo finance board, most active stocks—
(just a little pr)!!!
FDA approved, I’ll say it again the iT Bra is FDA Class11 approved.
Wrestler good find on the AI article...tic toc!
Great deal on the iT Bra sign up. Do all u can to get info out, my mom died from not getting breast check ups on a regular basis (cancer in the limpnods=too late).
The past 6 months I’ve texted, emailed, twittered, post on unrelated yahoo article comment section & even left a flyer sign here at Mercy Virtual in Chesterfield MO...over 500 contacts... actually more.
Cisco, news stations foreign & domestic, iFlytec, Med Cos, Twitter, Cancer Sites, Doctors specializing in
Breast cancer-one name Leeds to another...Point of Life !
My wife has repeatedly contacted Cyrcadia Health- Asia-iFlytec-Hospital Chains etc asking where she can buy the iT Bra as well as several of her friends. Squeeky wheel gets noticed...All of u let your contacts know Facebook etc. Tic Toc...
Jim Holmes, Lifeline’s CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product”.
Oh Leprissonnier I’ll but ya Jim Holmes won’t be calm when this game changer is released...I’m actually thinking about raising my sell order price, because when pinks blow they explode, you can hardly keep your
eyes from glazing over-heart thumping-if you have level 2 it’s exciting & Jim will be there with us !
By the way thanks for the website update, I would have missed it...
2018 Good article, if already posted disregard, unless newbie.
https://endpoints.elysiumhealth.com/next-generation-wearables-2018-b0c8be461151
E is right on & this pink stk below is an example of LLBO future, but higher PPS $$$.
PINK SUNTF 0.02 +2,757.14
Asia Market China here we come...(Most of you have a probably read this so obviously disregard if you have)!
China strives to lower cost of cancer drugs as disease rates soarJoy PersaudJoy PersaudJuly 16, 2018
China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.
The country’s cancer rates have soared in recent years, caused by people succumbing to the disease due to heavy smoking, pollution and living to an older age, raising concerns about the prevalence of the disease.
Last year, the National Cancer Center reported that there were 4.29 million new cases of the disease every year and 2.81 million deaths.
The five-year cancer survival rate was just 30% in 2015, less than half the US level, prompting the Chinese government to pledge to improve on this by 15 percentage points by 2030.
China’s new medical insurance regulator, The State Medical Insurance Administration, is planning to include more cancer drugs on its list of medicines eligible for reimbursement.
So far, 10 foreign and eight domestic pharmaceutical companies have expressed a willingness to work with the administration to boost availability so more people can benefit from medication, as more drugs are added to the insurance system.
China removed tariffs on all imported cancer drugs from May 1, following a decision by Premier Li Keqiang in April.
Breast cancer is the most common type of cancer in women in China. Data shows that this cancer has increased at a rate of around 3.5% a year from 2000 to 2013, compared with a drop of 0.4% a year over the same period in the US.
Levels are highest in urban areas. In small cities with a population below 500,000, the incidence of breast cancer is 30 per 100,000. For large cities with a population above 1 million, the incidence is 60 per 100,000 women.
iFLYTEK, a global AI giant, has recently invested in breast cancer detection smart bra manufacturer, Cyrcadia Asia. In Asia, many women either cannot access healthcare, or are unable to expose their bodies due to social, economic, or religious reasons. For women in many of these countries, discovery of the disease comes too late, and treatment is ineffective.
The iTBra contains two breast patches that detect circadian temperature changes within breast tissue. Anonymised data obtained from the iTBra is communicated directly to the Cyrcadia Health core lab for analysis via PC or smartphone.
Cyrcadia Asia operates under a strategic license and cooperation agreement with US-based Cyrcadia Inc to exclusively manufacture and commercialise the product for markets in Asia.
Lefty, not much longer & they will know it...It’s a blast though when one of these takes off...$
2nd round A financing should be starting...up.Money+Opportunity+Timing = BuyOut Tic toc tic toc...$
Rob Royea Twitter
#DailyNews, June 22, 2018 (GMT+8)
iFLYTEK, in cooperation with Cyrcadia Asia to integrate core AI technology of intelligent voice into breast cancer prevention.
#WeChat #JD #iFLYTEK #CyrcadiaAisa #Google #Facebook #Microsoft #AI #MachineLearning #DeepLearning
“WORLDS LARGEST DATABASE”
iFlytek ‘s medical department was established in 2016 and is led by Dr. Tao Xiaodong, a senior technical expert from Philips and GE Healthcare. Dr. Tao Xiaodong, General Manager of iFlytek Smart Healthcare, has extensive experience in medical imaging and computer-aided diagnostics. The iFlytek has also made rapid progress in medical + artificial intelligence in the past two years. In November 2017, the company’s “Little Doctor” artificial intelligence robot successfully passed the national medical examination, and the Chinese doctor qualification examination scored 456 points, 96 points higher than the qualified standard. In addition, iFlytek currently deploys artificial intelligence services in more than 50 hospitals in Anhui Province to provide GPs with diagnostic, therapeutic and interpretation support for medical images including breast imaging.
With the completion of this financing, iFlytek will also work with Cyrcadia Asia to explore how to integrate Cyrcadia’s technology into iFlytek ‘s medical products in China. At the same time, Dr. Tao Xiaodong also joined the board of directors of Cyrcadia Asia.
Dr. Tao Xiaodong commented on this investment: “We are very pleased to play a leading role in Cyrcadia’s technology development and market launch. iFlytek has already practiced the power of artificial intelligence in the medical field, and Cyrcadia’s technology uses metabolic changes to detect Diseases, which can overcome and compensate for the many shortcomings of current imaging technology and manual interpretation. We are also pleased with Cyrcadia’s consumer wearable device technology, which provides women with the convenience and possibility to monitor their health in real time. With the growth of the group, it is likely to become the world’s largest database of breast health and breast cancer, and we hope that in the near future we will be able to make significant contributions to the research, prevention and treatment of this disease.”
“WE ARE EXCITED. RAISED $3.6 BILLION AND “”ACCELERATING”” INVESTMENTS”
"We are excited to play a leading role in the development and launch of Cyrcadia’s technology. iFlytek is already harnessing the power of AI in healthcare, but Cyrcadia’s technology, by using metabolic change to detect disease, can leapfrog many of the current drawbacks of imaging and human interpretation. We are also excited by the promise of Cyrcadia’s technology as a consumer wearable device, providing real-time monitoring for women at their own convenience," said iFlytek Health’s CEO Tao Xiaodong.
In addition to the investment, iFlytek and Cyrcadia Asia will be exploring how to integrate Cyrcadia’s technology into iFlytek’s healthcare offering in China.
iFlytek is best known for its voice-recognition technology, but the company is also accelerating investment in other AI applications, including healthcare and smart vehicle. In May, it announced plans to raise up to RMB3.6 billion (US$567 million) through private placement to expand its artificial intelligent investments.
“SHORTCOMING IN CURRENT IMAGING TECHNOLOGIES”
Iflytek is the biggest artificial intelligence firm listed in China, and began its foray into healthcare in 2016. Dr. Tao Xiaodong, an expert with medical imaging and computer-aided diagnosis experience at Philips Healthcare and GE Healthcare, founded the department and is set to become a director at Cyrcadia Asia.
The patches detect cancer by observing metabolic changes, Tao said. This makes up for shortcoming in current imaging technologies and human interpretation, and provides a convenient way for women to monitor their health. The increasing number of users could make the service the largest breast health incidence database, and provide information for research into cancer preventions and treatments, he added.
Iflytek took quickly to the healthcare sector, and in November 2017 its AI robot Xiaoyi passed the national medical exam, the test required to qualify as a doctor in China. The bot scored 456 points, 96 more than the pass mark. The company now runs AI services at more than 50 hospitals in its home province an Anhui, helping doctors to diagnose and treat diseases and interpret medical images.
“500 MILLION PEOPLE”
Business Impact
Why 500 Million People in China Are Talking to This AI
iFlytek’s voice recognition technology is everywhere in China, and that’s what’s making it smarter every day.
by Yiting Sun September 14, 2017
In China, over 500 million people use iFlytek Input to overcome obstacles in communication such as the one Xu faces. Some also use it to send text messages through voice commands while driving, or to communicate with a speaker of another Chinese dialect. The app was developed by iFlytek, a Chinese AI company that applies deep learning in a range of fields such as speech recognition, natural-language processing, machine translation, and data mining (see “50 Smartest Companies 2017”).
“FAR AHEAD OF THE USA”
China counts on AI to find a cure for its ailing health care system
TECH NEWS
Monday, 2 Jul 2018 ?12:00 PM MYT
Read more at http://www.scmp.com/tech/china-tech/article/2153144/china-counts-ai-find-cure-its-ailing-health-ca
“China is already far ahead of the US in AI enabled diagnosis,” said Ni Hao, health care chief executive at Yitu Technology, a Shanghai-based AI start-up that specialises in facial recognition systems. There are two reasons for that, according to Ni. First, the shortage of doctors in the US is not as dire as in China, and second, US AI-start ups may not be able to afford a large medical team because American doctors earn between US$250,000.
“INITIAL
DIAGNOSIS”
iFlytek boosts use of AI in healthcare sector
2017-12-04 09:24 China Daily Editor: Wang Zihao-
Doctors there are well served by a smart, well-qualified assistant. 'She' records patients' symptoms, reviews computerized tomography scan images and makes initial diagnosis. Only, she is not human but a robot that runs on artificial intelligence.
Developed by iFlytek Co Ltd, a leading Chinese AI company, the robot aced the written test of China's national medical licensing examination-it is a test that aspiring doctors need to pass-in November, thus becoming the first device in the world to achieve the feat. It received 456 marks, 96 more than the minimum required to qualify.
In November, iFlytek was chosen by the central government as one of the four tech heavyweights to build the national AI open innovation platform by leveraging voice computing technologies.
Conclusion:
Elementary my dear Watson, the iT Bra has brilliantly timed it’s arrival in Asia, we must act fast and buy shares
of LLBO before this monster iFlytek gobbles them up. Brilliant Holmes, I was wondering just how much longer
you were going to smell this one out.
Well fellow investors we all like to talk about are investments made with are hard earned money, but this is one
I have finally reached a confidence level of enormous gratitude and realistically see a high probability of being
aquiered $$$. iFlytec Co. Is all over this, and ripe with Billions in investment money. ???
Just like Cytosorbents, they creep in & try to steal your shares, slithering around like coakroaches on parade.
But we won’t let them in men stand tall & proud, because soon one day we will bask in a sunshine of undeniable glory, gleaming in share delight of our unyielding undeniable uncompromising success.
Then & only then will they slither away, to crap on another...
LLBO$$$
Just like Cytosorbents, they creep in & try to steal your shares, slithering around like coakroaches on parade.
But we won’t let them in men stand tall & proud, because soon one day we will bask in a sunshine of undeniable glory, gleaming in share delight of our unyielding undeniable uncompromising success.
Then & only then will they slither away, to crap on another...
LLBO$$$
The Mary Kay Foundation
Cancer News And How It Affects You
05-17-2017 9:09 AM
Welcome to The Wednesday Report. This week, we’re giving you the top headlines in cancer news and how it might affect you:
The breast cancer doctors missed. Inflammatory breast cancer made international headlines this month when a Texas mom of two told her story. When Jennifer Cordts noticed a rash on her breast — much like a sunburn — she got medical help. Unfortunately, the mammogram showed no lump and no tumor. And her lab work returned normal. So, no diagnosis. When the redness didn’t go away, she turned to the Internet. After pressing her doctors for more answers, she was finally diagnosed with stage four, inflammatory breast cancer. That diagnosis came nearly one year after her initial symptoms. You can see her entire story here.
What you can learn. Unfortunately, inflammatory breast cancer symptoms mimic other diseases and conditions. That’s why doctors miss it. We want to spread the word about the symptoms. Women, trust your instincts. Don’t be afraid to get a second opinion. And know the signs. For more information, to cancer.gov.
Can a bra help with early detection? Maybe. I read about two types this week.
Bra inserts. The iTBra inserts, by Cyrcadia Health, may be ready for market launch in Asia in late 2017 or early 2018. The iTBra consists of two wearable breast patches, which can fit inside any bra, that detect temperature changes within breast tissue. Heat changes within breasts can be a very early sign of cancer. This new technology offers advantages especially to women with dense breasts. Mammograms can often miss small tumor growth in dense breasts.
The U.S. FDA has already approved the itBra sensors. Clinical trials in the U.S. show an 80 percent accuracy rate of detecting tumors, which compares with mammography. So why the launch in Asia first? Seventy percent of Asian women have dense breast tissue, which leads to a higher tendency to develop breast cancer. That compares to only 40 percent in the western population. However, Cyrcadia expects to launch in North America shortly after the Asian launch. You can read the entire press release here.
Teen boy invents smart bra in honor of his mom. Everybody loves a feel-good news story. And that’s exactly the story of Julián Ríos Cantú. This 18-year-old boy won the top prize at the Global Student Entrepreneur Awards for creating an intelligent bra that can help detect breast cancer. The reason? He almost lost his mom to breast cancer. Don’t look for the bra anytime soon as it hasn’t gone through any clinical trials. But you read all about it here.
Let us know what you think about our first issue of The Wednesday Report. We always love to hear from you.
Stacy Graves is a contributing editor of The Mary Kay Foundation? blog and website. She and her husband, Glen, are raising two teen boys. When she’s not writing, she’s probably at a fitness class, volunteering at church or the boys’ school, or drinking a healthy smoothie at the local juice bar. She’s worked in some type of communication role for Mary Kay Inc. or The Mary Kay Foundation since 1994 — loving every minute. She’s passionate about everything Mary Kay. You can connect with her by her website or LinkedIn.
tagged: cancer, breast cancer, 2017, The Wednesday Report
(And like the broken record I am fellow longs, again my god this is beginning to remind me of my long hold of Cytosorbent shares, it’s coming, no crystal ball how high, but IT IS COMING !)
Luke Minford, CEO of Rouse, said:
“We are delighted to see Cyrcadia Asia close its seed funding, especially with a lead investor as exciting as iFlytek, and we look forward to supporting the next stage of the company’s growth. Rouse has always been an entrepreneurial firm that is dedicated to helping companies obtain real value from their intellectual property assets. Our Ventures program proves that we can go beyond traditional consulting services and be instrumental in bringing a ground-breaking and potentially life-saving technology to the world. We are fortunate to have found in SCP a partner with outstanding contacts and experience in capital raising who can work so seamlessly with us.”
Tic tic tic tic and...TOC, no doubt it’s going to happen:)
Hell after holding Cytosorbents for 8 yrs and all the negativity, filter for sepsis will never work, bashers, etc. It
finally exploded...!$$$
Lefty .05 PLUS PPS easily...GOOD example follows, Stock I sold ~3yrs ago. I just found this article released published on 8/29/2018: Really like the last sentence “Pop on takeover speculation”..$$$
Cytosorbents Stock Could Score Big With Its Blood-Filtering Technology
Dana Blankenhorn
InvestorPlaceAugust 29, 2018, 5:03 PM CDT
Cytosorbents (NASDAQ:CTSO) is something of a hit in Europe but is virtually unknown in the U.S.
Its blood-filtering technology, based on porous polymer beads that actively remove specific toxins from blood and other bodily fluids, is being built into a host of filtering products with names like CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, and DrugSorb.
One of these, CytoSorb is already used to filter blood in 53 countries. and that led to a record $5.8 million in revenue for the second quarter of this year. European regulators seem pleased with its ability to filter toxins from blood. So far in 2018, CTSO stock has nearly doubled.
But Cytosorbents’ products are not yet sold in the U.S. As a result, the company has a market cap of only $409 million. Its 2017 sales were just $15 million, but it has $25 million of cash in the bank and debts of less than $10 million.
“I suspect, however, that the company may not have the scale to succeed quickly. CTSO stock could, however, get a pop on takeover speculation, and that’s the catalyst investors may be looking for.”
End
(Also, CytoSorb only has UE approval, NO FDA.)
Below is my previous post, BEFORE I read the above article (do Google search to read above article in its intirety).
CTSO a stock I bgt & posted on many
Yrs ago (for the record I sold in 2015, 8 yr hold) now has only $9Mil revenue, negative EPS & with roughly
28 Mil S/O (shares outstanding) $14.95/PPS, has a market cap of approximately $450,000,000 Million. “Seriously only 9 Mil in sales???” What do you think will happen to LLBO (45% stake) in Cyrcadia Health most likely sooner than later $$$. I stick firmly by my previously posted PPS targets. (And just today added, AND then some).
Pharma do u and Homebrew work together, I was in this stock in 08, and glad I’m still in.
Time for u to brew somewhere else
WW11 carpet bombing was not so effective, now we have smart bombs bigger payloads & target specific...well what’s that sound like? The evolution of the iT Bra, Much improved thermal sensors & most important breast incident location, incident location is “Huge” & I don’t believe this has caught on as yet.
As previous posters have stated Cisco, iFlytec, why are they in the game, because they know this tech will be a game changer. iFlytech chief medical officer “We will build the worlds largest breast incident diognostic data base”. What?
Kaiser Permanente Hosp. currently in discussions with Cyrcadia Health, Mercy Virtual (of which I’ll get to in a minute), & the other med virtual groups (in new Investor post) will be all over this, they wanted clinical data well now they will get it.
Many of the original investment groups, which are in my new Investor post have new product sales market targets of $100 Million revenue or larger for them to invest. So how does that compare to other stocks. CTSO a stock I bgt & posted on many
Yrs ago (for the record I sold in 2015, 8 yr hold) now has only $9Mil revenue, negative EPS & with roughly
28 Mil S/O (shares outstanding) $14.95/PPS, has a market cap of approximately $450,000,000 Million. “Seriously only 9 Mil in sales???” What do you think will happen to LLBO (45% stake) in Cyrcadia Health most likely sooner than later $$$. I stick firmly by my previously posted PPS targets.
Sorry, another Confirm long post, but back to Mercy Virtual (as previously posted only 6 miles from my house
virtual medical bldg with hundreds of nurses, techs & doctors-I know hard to get you head around it, servicing
the mid west). Good friend of mines wife is a nurse practitioner works out of home works with doctors admin & Ins folks everyday Mercy is a client. Discussed info listed above, specifically location of breast incident, to sum up her words “ Game Changer”, if accuracy is there.
PCM- yes good article, good find thanks. Rob Royea, CA had mentioned the fact that they are
now able to use iT Bra AI for breast lesion location, this is HUGE. Really huge...
This simply puts much more credibility on detected vs me to.
This will bring the iT Bra into the cross-hairs... in the USA.
News, the only new news I’ve seen is the recent financials, other than the iFlytec interest, CA iT Bra 2018 planned Asia relelease, new employees & board of directors news releases...
BUT, currently the only news I’m waiting for now, & some of u have mentioned is—
1)Consumer release of iT Bra in Asia
2)FDA Class 1 approval (have class 2 already)
3)Signed deal with Kaiser Permanente
WHY—
1)The consumer release of iT Bra in my opinion will be huge, iFlytec already recognized & respected in Asia has a huge mkt for it & per my recent post has MADE it pretty dam clear they want a AI breast diognostic incident data base of mega size...& the only way to do that is having many women wearing the iT Bra(the fall out of this will not only be SALES, but extreme recognition by
USA based virtual medical industry such as Kaiser Medical & it’s competitors, as well as others.).
2)Class 1 approval, we’ll need I say more !!! (But, we have class 2, “a bird in hand”).
3)Kaiser Permanente, well the answer should be pretty obvious by now !
1)Mercy Virtual 2)Kaiser Permanente 3)Cleveland Clinic 4)Intermountain Health Care, 5)Dignity Health,
6) Avera Health—just names of mega hospital healthcare providers with Virtual networks with millions of patients, all could contribute to a mega incident data base for breast cancer analysis.
Tic tic tic tic...
Flytec(Keda Xunfei) & Cyrcadia Health
Bloomberg Nov, 2017 iFlytec video (6 months after iT Bra investment)
“China’s iFlytec focuses on smart healthcare” quoted...
—“Smart Healthcare growth (acquisition) is the primary Company smart tech strategic focus”
—“Assisted diognostic system accuracy for improved cancer diognosis through AI imaging”
—“Out International strategy of investing in USA Co’s WILL assist this goal”
—“Activities are being conducted at our new Silicon Valley office”
(iFlytec is the primary $3.8 Million only Investor)
Read between the lines, LLBO S/B trading above .05 cents per share. TOC
Don’t be caught at the airport...
iFlytec(Keda Xunfei) & Cyrcadia Health
Bloomberg Nov, 2017 iFlytec video (6 months after iT Bra investment)
“China’s iFlytec focuses on smart healthcare” quoted...
—“Smart Healthcare growth (acquisition) is the primary Company smart tech strategic focus”
—Assisted diognostic system accuracy for improved cancer diognosis through AI imaging”
—“Out International strategy of investing in USA Co’s WILL assist this goal”
—Activities are being conducted at our new Silicon Valley office”
(iFlytec is the primary $3.8 Million only Investor to Cyrcadia Asia)
Read between the lines, LLBO S/B trading above .05 cents per share.